Patricia Caetano
Winnipeg, MB R3B3M9, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Considerations for Developing a Reassessment Process: Report from the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration's Reassessment and Uptake Working Group.
Journal: Current oncology (Toronto, Ont.)
Published: August 28, 2021
Leveraging policy to reduce chronic opioid use by educating and empowering community dwelling adults: a study protocol for the TAPERING randomized controlled trial.
Journal: Trials
Published: November 16, 2018
Changes in the dispensing of opioid medications in Canada following the introduction of a tamper-deterrent formulation of long-acting oxycodone: a time series analysis.
Journal: CMAJ open
Published: November 24, 2017
Trends and uptake of new formulations of controlled-release oxycodone in Canada.
Journal: Pharmacoepidemiology and drug safety
Published: August 04, 2017
Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis.
Journal: JAMA internal medicine
Published: August 02, 2016
Physical comorbidities increase the risk of psychiatric comorbidity in multiple sclerosis.
Journal: Brain and behavior
Published: January 15, 2016
Supporting collaborative use of the Diabetes Population Risk Tool (DPoRT) in health-related practice: a multiple case study research protocol.
Journal: Implementation science : IS
Published: January 22, 2014
Prevalence and incidence of ischemic heart disease in multiple sclerosis: A population-based validation study.
Journal: Multiple sclerosis and related disorders
Published: December 21, 2012
Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia.
Journal: Multiple sclerosis (Houndmills, Basingstoke, England)
Published: February 14, 2012
Last Updated: 09/26/2026